NEW YORK (GenomeWeb) – OpGen announced today that it has priced its public offering of approximately 3.7 million units of common stock and common warrants at $3.25 per unit.

The firm expects to raise $12 million in gross proceeds.

Each unit being offered is comprised of one share of common stock and one common warrant to purchase one-half of a share of common stock. Each common warrant will expire five years from the issuance date.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.